Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

June 01, 1996; Volume 277,Issue 3
  • You have access
    Use of digitalis glycosides to identify the mechanisms of amantadine transport by renal tubules.
    M R Escobar and D S Sitar
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1189-1194;
  • You have access
    Possible contribution of platelet cyclooxygenase to the renal vascular action of 5,6-epoxyeicosatrienoic acid.
    D Fulton, M Balazy, J C McGiff and J Quilley
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1195-1199;
  • You have access
    The zinc pool is involved in the immune-reconstituting effect of melatonin in pinealectomized mice.
    E Mocchegiani, D Bulian, L Santarelli, A Tibaldi, M Muzzioli, V Lesnikov, W Pierpaoli and N Fabris
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1200-1208;
  • You have access
    Catecholamine secretion induced by nicotine is due to Ca++ channel but not Na+ channel activation in porcine adrenal chromaffin cells.
    Q Li and E J Forsberg
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1209-1214;
  • You have access
    ATP-sensitive potassium channel modulators: both pinacidil and glibenclamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats.
    I Leprán, I Baczkó, A Varró and J G Papp
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1215-1220;
  • You have access
    Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems.
    L M Lichtenberger, C Ulloa, A L Vanous, J J Romero, E J Dial, P A Illich and E T Walters
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1221-1227;
  • You have access
    Comparative clinical pharmacology of short-acting mu opioids in drug abusers.
    M K Greenwald, H L June, M L Stitzer and A P Marco
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1228-1236;
  • You have access
    Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery.
    R Testa, L Guarneri, C Taddei, E Poggesi, P Angelico, A Sartani, A Leonardi, O N Gofrit, S Meretyk and M Caine
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1237-1246;
  • You have access
    The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats.
    S E Hemby, J E Smith and S I Dworkin
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1247-1258;
  • You have access
    Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats.
    W P Clarke, F D Yocca and S Maayani
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1259-1266;
  • You have access
    Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat.
    J Rochford, A P Sen and R Quirion
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1267-1275;
  • You have access
    Inogatran, a novel direct low molecular weight thrombin inhibitor, given with, but not after, tissue-plasminogen activator, improves thrombolysis.
    L Chen, W W Nichols, C Mattsson, A C Teger-Nilsson, T G Saldeen and J L Mehta
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1276-1283;
  • You have access
    Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
    R J Knapp, G Santoro, I A De Leon, K B Lee, S A Edsall, S Waite, E Malatynska, E Varga, S N Calderon, K C Rice, R B Rothman, F Porreca, W R Roeske and H I Yamamura
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1284-1291;
  • You have access
    Effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1 -H-1-benzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, on impaired learning and memory in animal models.
    M Miyamoto, H Takahashi, K Kato, K Hirai, Y Ishihara and G Goto
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1292-1304;
  • You have access
    A comparison of the effects of valproate and its major active metabolite E-2-en-valproate on single unit activity of substantia nigra pars reticulata neurons in rats.
    A Rohlfs, C Rundfeldt, R Koch and W Löscher
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1305-1314;
  • You have access
    delta 9-Tetrahydrocannabinol selectively inhibits macrophage costimulatory activity and down-regulates heat-stable antigen expression.
    D J Clements, G A Cabral and K L McCoy
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1315-1321;
  • You have access
    Buprenorphine differentially alters opioid receptor adaptation in rat brain regions.
    M M Belcheva, M T Ho, E G Ignatova, L B Jefcoat, J Barg, Z Vogel, R J McHale, F E Johnson and C J Coscia
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1322-1327;
  • You have access
    Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
    K Miyoshi, A Kanda, Y Nozawa, M Nakano and H Miyake
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1328-1336;
  • You have access
    Evidence of a bradykinin B1 receptor in human ileum: pharmacological comparison to the rabbit aorta B1 receptor.
    J S Zuzack, M R Burkard, D K Cuadrado, R A Greer, W M Selig and E T Whalley
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1337-1343;
  • You have access
    Perinatal methadone exposure produces physical dependence and altered behavioral development in the rat.
    P M Kunko, J A Smith, M J Wallace, J R Maher, J J Saady and S E Robinson
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1344-1351;
  • You have access
    A-4, a tertiary amine analog of HC-3, lowers arterial pressure in spontaneously hypertensive rats.
    U Ozkutlu, R A Shaffer, S J Lewis and J P Long
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1352-1358;
  • You have access
    Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome.
    W L Hasler, H C Soudah and C Owyang
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1359-1365;
  • You have access
    Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability.
    D L Greene, V S Hau, T J Abbruscato, H Bartosz, A Misicka, A W Lipkowski, S Hom, T J Gillespie, V J Hruby and T P Davis
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1366-1375;
  • You have access
    Heme oxygenase inhibitor zinc protoporphyrin IX causes an activation of nitric oxide synthase in the rabbit internal anal sphincter.
    S Chakder, S Rathi, X L Ma and S Rattan
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1376-1382;
  • You have access
    Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes.
    M J Marks, S F Robinson and A C Collins
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1383-1396;
  • You have access
    Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells.
    F E Parkinson and J D Geiger
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1397-1401;
  • You have access
    Rates of glutathione synthesis in lung subcompartments of mice and monkeys: possible role in species and site selective injury.
    X Duan, C Plopper, P Brennan and A Buckpitt
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1402-1409;
  • You have access
    L-deprenyl (selegiline) exerts anticonvulsant effects against different seizure types in mice.
    W Löscher and H Lehmann
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1410-1417;
  • You have access
    Effect of endotoxin on permeability of bovine cerebral endothelial cell layers in vitro.
    H E de Vries, M C Blom-Roosemalen, A G de Boer, T J van Berkel, D D Breimer and J Kuiper
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1418-1423;
  • You have access
    NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
    H Inoue, I Arai, S Shibata and S Watanabe
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1424-1430;
  • You have access
    Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A.
    A N Gifford and C R Ashby
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1431-1436;
  • You have access
    Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
    C Pifl, O Hornykiewicz, B Giros and M G Caron
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1437-1443;
  • You have access
    Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats.
    J Song, P R Standley, F Zhang, D Joshi, S Gappy, J R Sowers and J L Ram
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1444-1453;
  • You have access
    Electrophysiological effects of a novel, short-acting and potent ester derivative of amiodarone, ATI-2001, in guinea pig isolated heart.
    M J Raatikainen, C A Napolitano, P Druzgala and D M Dennis
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1454-1463;
  • You have access
    Nonsteroidal anti-inflammatory drugs activate carbonic anhydrase by a direct mechanism of action.
    I Puscas, M Coltau and R Pasca
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1464-1466;
  • You have access
    Alterations in locomotor activity after microinjections of GBR-12909, selective dopamine antagonists or neurotensin into the medial prefrontal cortex.
    R A Radcliffe and V G Erwin
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1467-1476;
  • You have access
    Alternations in splenocyte and thymocyte subpopulations in B6C3F1 mice exposed to cocaine plus diazinon.
    D F Kump, R A Matulka, G F Burton, S D Jordan and M P Holsapple
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1477-1485;
  • You have access
    Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
    R K Handa and J W Strandhoy
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1486-1491;
  • You have access
    Regional hemodynamic effects of purinergic P2 receptor subtype agonists in rats.
    B F Cox and G J Smits
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1492-1500;
  • You have access
    Mechanisms of [Ca++]i elevation induced by erythrocyte components in endothelial cells.
    H Zhang, B K Weir, R L Macdonald, L S Marton, N J Solenski, A L Kwan and K S Lee
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1501-1509;
  • You have access
    Neural and endocrine circuits mediating inhibition of bradykinin-induced plasma extravasation by subcutaneous and spinal-intrathecal nicotine.
    F J Miao, N Benowitz and J D Levine
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1510-1516;
  • You have access
    The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
    G E Billman and R L Hamlin
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1517-1526;
  • You have access
    Protein kinase C activators decrease dopamine uptake into striatal synaptosomes.
    B J Copeland, V Vogelsberg, N H Neff and M Hadjiconstantinou
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1527-1532;
  • You have access
    Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status.
    D T Lysle, K E Hoffman and L A Dykstra
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1533-1540;
  • You have access
    Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade.
    C J Schmidt and G M Fadayel
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1541-1549;
  • You have access
    Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier.
    A Kakee, T Terasaki and Y Sugiyama
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1550-1559;
  • You have access
    LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.
    D J Cushing, J M Zgombick, D L Nelson and M L Cohen
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1560-1566;
  • You have access
    Nonpeptide endothelin receptor antagonists. VII: Binding characteristics of [3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors.
    P Nambi, M Pullen, H L Wu, D Lee, D Saunders, R Heys, N Aiyar, J Leber, J Elliott, D Brooks, E Ohlstein and R Ruffolo
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1567-1571;
  • You have access
    Positive inotropic effects of the calcium sensitizer CGP 48506 in guinea pig myocardium.
    N Zimmermann, P Bokník, E Gams, J W Herzig, J Neumann, W Schmitz, H Scholz and H Wenzlaff
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1572-1578;
  • You have access
    Positive inotropic effects of the calcium sensitizer CGP 48506 in failing human myocardium.
    J Neumann, T Eschenhagen, I L Grupp, A Haverich, J W Herzig, S Hirt, P Kalmár, W Schmitz, H Scholz, B Stein, H Wenzlaff and N Zimmermann
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1579-1585;
  • You have access
    Differential effects of unique profile antipsychotic drugs on extracellular amino acids in the ventral pallidum and globus pallidus of rats.
    M A Chapman and R E See
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1586-1594;
  • You have access
    Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist.
    D H Albert, R G Conway, T J Magoc, P Tapang, D A Rhein, G Luo, J H Holms, S K Davidsen, J B Summers and G W Carter
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1595-1606;
  • You have access
    Platelet-activating factor production in stimulated macrophages is down-regulated by concurrently produced prostaglandin E2.
    M Yamada, M Watanabe, S Mue and K Ohuchi
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1607-1614;
  • You have access
    Active transport of cimetidine and ranitidine into the milk of Sprague Dawley rats.
    P J McNamara, J A Meece and E Paxton
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1615-1621;
  • You have access
    Involvement of endothelins in immediate and late asthmatic responses of guinea pigs.
    Y Uchida, T Jun, H Ninomiya, H Ohse, S Hasegawa, A Nomura, T Sakamoto, M S Sardessai and F Hirata
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1622-1629;
  • You have access
    Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach.
    T Izumi, S Enomoto, K Hosiyama, K Sasahara, A Shibukawa, T Nakagawa and Y Sugiyama
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1630-1641;
  • You have access
    Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists.
    Y W Lee and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1642-1648;
  • You have access
    Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate.
    R R Arlen and P G Wells
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1649-1658;
  • You have access
    The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways.
    K K Nielsen, J P Flinois, P Beaune and K Brøsen
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1659-1664;
  • You have access
    Protection from 1,1-dichloroethylene-induced Clara cell injury by diallyl sulfone, a derivative of garlic.
    P G Forkert, R P Lee, T F Dowsley, J Y Hong and J B Ulreich
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1665-1671;
  • You have access
    Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1.
    K Fukuda, H Dan, M Takayama, F Kumano, M Saitoh and S Tanaka
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1672-1675;
  • You have access
    Suppressed expression of phenobarbital-inducible hepatic cytochrome P-450s in Eisai-hyperbilirubinuria rats (EHBR/Eis).
    T Oguro, E Kaneko, Y Kaneko, S Numazawa, S Imaoka, Y Funae, T Mikami and T Yoshida
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1676-1684;
  • You have access
    Effects of nicotine on dopaminergic nigrostriatal axons requires stimulation of presynaptic glutamatergic receptors.
    M Garcia-Munoz, P Patino, S J Young and P M Groves
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1685-1693;
  • You have access
    Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease.
    A A Nanji, E K Yang, F Fogt, S M Sadrzadeh and A J Dannenberg
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1694-1700;
  • You have access
    Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension.
    M Kähönen, H Mäkynen, X Wu, P Arvola, A Pekki and I Pörsti
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1701-1709;
  • You have access
    Selective suppression of rat hepatic microsomal activity during chronic cyclosporine nephrotoxicity.
    L J Brunner, W M Bennett and D R Koop
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1710-1718;
  • You have access
    Hydrogen peroxide mediates the killing of U937 tumor cells elicited by pharmacologically attainable concentrations of ascorbic acid: cell death prevention by extracellular catalase or catalase from cocultured erythrocytes or fibroblasts.
    P Sestili, G Brandi, L Brambilla, F Cattabeni and O Cantoni
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1719-1725;
  • You have access
    Inorganic mercury chloride-induced apoptosis in the cultured porcine renal cell line LLC-PK1.
    K B Duncan-Achanzar, J T Jones, M F Burke, D E Carter and H E Laird
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1726-1732;
  • You have access
    The membrane hyperpolarization of rat dorsolateral septal nucleus neurons is mediated by a novel nicotinic receptor.
    E M Sorenson and J P Gallagher
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1733-1743;
  • You have access
    In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine-kinase-dependent mechanism.
    M D Sauro, R Sudakow and S Burns
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1744-1750;
  • You have access
    Adrenergic regulation of the heat shock response in brown adipose tissue.
    J M Matz, K P LaVoi and M J Blake
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1751-1758;
  • You have access
    Effects of felbamate on muscarinic and metabotropic-glutamate agonist-mediated responses and magnesium-free or 4-aminopyridine-induced epileptiform activity in guinea pig olfactory cortex neurons in vitro.
    V Libri, A Constanti, M Zibetti and S Nisticó
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1759-1769;
  • You have access
    Characterization and localization of [125I]RTI-55-labeled cocaine binding sites in fetal and adult rat brain.
    L P Shearman, L M Collins and J S Meyer
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1770-1783;
  • You have access
    Felbamate inhibits [3H]t-butylbicycloorthobenzoate (TBOB) binding and enhances Cl- current at the gamma-aminobutyric AcidA (GABAA) receptor.
    A Kume, L J Greenfield, R L Macdonald and R L Albin
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1784-1792;
  • You have access
    Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway.
    F Pica, O Franzese, C D'Onofrio, E Bonmassar, C Favalli and E Garaci
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1793-1800;
  • You have access
    Type II collagen-induced arthritis in the diabetic-resistant biobreeding rat: inflammatory and histopathological features of joint pathology and effects of antiinflammatory and antirheumatic drugs on this chronic arthritic process.
    R J Smith and L M Sly
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1801-1813;
  • You have access
    Renal ischemia/reperfusion up-regulates heme oxygenase-1 (HSP32) expression and increases cGMP in rat heart.
    V S Raju and M D Maines
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1814-1822;
  • You have access
    Regional distribution and characterization of [3H]dextrorphan binding sites in rat brain determined by quantitative autoradiography.
    J E Roth, T F Murray and P H Franklin
    Journal of Pharmacology and Experimental Therapeutics June 1996, 277 (3) 1823-1836;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 277, Issue 3
1 Jun 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Manifestations of METH Neurotoxicity
  • Ocular Drug Delivery: Past, Present, and Future
  • Noradrenergic Mechanisms in Fentanyl Rapid Death
  • Acalabrutinib: A Differentiated Covalent BTK Inhibitor
  • Cannabis Therapy for Refractory Epilepsy
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics